BlackRock Inc. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 30 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$169,000
+59.4%
83,714
+12.6%
0.00%
Q1 2022$106,000
-7.0%
74,357
+6.5%
0.00%
Q4 2021$114,000
-46.2%
69,825
+5.2%
0.00%
Q3 2021$212,000
-90.6%
66,352
-85.4%
0.00%
Q2 2021$2,246,000
-28.0%
454,743
+20.3%
0.00%
Q1 2021$3,119,000
+4231.9%
378,036
+874.2%
0.00%
Q4 2020$72,000
+118.2%
38,804
+0.7%
0.00%
Q3 2020$33,000
-13.2%
38,549
+0.0%
0.00%
Q2 2020$38,000
-2.6%
38,546
-0.8%
0.00%
Q1 2020$39,00038,8560.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2022
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders